Vaccine

Moderna and Coursera Launch Free Course on mRNA Technology

Companies share joint commitment to leveraging technology for STEM educationAccessible education on cutting-edge science and technology represents critical step toward…

1 year ago

Vaccinex Provides Update on New Findings for SIGNAL-AD Phase 1b/2 Trial of Pepinemab in Alzheimer’s Disease and Plans to Pursue a Development Partnership

Company reviews goals and significance of the study and outlines development strategy in Mild Cognitive Impairment due to Alzheimer’s diseaseROCHESTER,…

1 year ago

IMUNON Reports Second Quarter 2024 Financial Results and Provides a Business Update

Conference Call Begins Today at 11:00 a.m. Eastern Time LAWRENCEVILLE, N.J., Aug. 14, 2024 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ:…

1 year ago

Cocrystal Pharma Reports Second Quarter 2024 Financial Results and Provides Updates on its Antiviral Drug-Development Programs

Expects to report topline results in 2025 from Phase 2a influenza A human challenge study with oral CC-42344, including initial…

1 year ago

Quantiphi Strengthens AI Drug Discovery, Development Collaboration with Transcell Through Strategic Minority Investment

MARLBOROUGH, Mass., Aug. 13, 2024 /PRNewswire/ -- Quantiphi, an award-winning AI-first digital engineering company today announced it has acquired a…

1 year ago

Verisante Technology, Inc. Announces Proposed RTO with SunRegen Healthcare AG

VANCOUVER, BC / ACCESSWIRE / August 13, 2024 / Verisante Technology, Inc. (TSX-V:VER.H) ("Verisante") is pleased to announce that it…

1 year ago

MedAdvisor Solutions Showcases Industry’s First AI-Driven Medication Advisor

Designed To Support Patient Engagement And Improve Access To Medication Information WOBURN, Mass., Aug. 13, 2024 /PRNewswire/ -- MedAdvisor Solutions, the…

1 year ago

Teknova Introduces Proprietary Express-Tek℠ Production Service and Expanded Manufacturing Grade Options to Expedite Novel Therapy Development

Express-TekSM Production enables customers to have their products enter production in days instead of weeks, significantly shortening turnaround time New…

1 year ago

PDS Biotech Provides Business Update and Reports Second Quarter 2024 Financial Results

PRINCETON, N.J., Aug. 13, 2024 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage…

1 year ago